HK1217444A1 - 用於改善肺功能和用於預防和/或治療輻射誘發的肺併發症的材料和方法 - Google Patents

用於改善肺功能和用於預防和/或治療輻射誘發的肺併發症的材料和方法

Info

Publication number
HK1217444A1
HK1217444A1 HK16105527.3A HK16105527A HK1217444A1 HK 1217444 A1 HK1217444 A1 HK 1217444A1 HK 16105527 A HK16105527 A HK 16105527A HK 1217444 A1 HK1217444 A1 HK 1217444A1
Authority
HK
Hong Kong
Prior art keywords
prevention
radiation
treatment
materials
methods
Prior art date
Application number
HK16105527.3A
Other languages
English (en)
Inventor
薩達希瓦‧維佳薩加爾
保羅‧奧庫尼夫
Original Assignee
Univ Of Florida Res Found Incorpor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51658958&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1217444(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Of Florida Res Found Incorpor filed Critical Univ Of Florida Res Found Incorpor
Publication of HK1217444A1 publication Critical patent/HK1217444A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK16105527.3A 2013-03-11 2016-05-13 用於改善肺功能和用於預防和/或治療輻射誘發的肺併發症的材料和方法 HK1217444A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361775754P 2013-03-11 2013-03-11
PCT/US2014/023363 WO2014164736A1 (en) 2013-03-11 2014-03-11 Materials and methods for improving lung function and for prevention and/or treatment of radiation-induced lung complications

Publications (1)

Publication Number Publication Date
HK1217444A1 true HK1217444A1 (zh) 2017-01-13

Family

ID=51658958

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16105527.3A HK1217444A1 (zh) 2013-03-11 2016-05-13 用於改善肺功能和用於預防和/或治療輻射誘發的肺併發症的材料和方法

Country Status (12)

Country Link
US (4) US10350185B2 (zh)
EP (2) EP3427730B1 (zh)
JP (3) JP6378307B2 (zh)
KR (3) KR101969199B1 (zh)
CN (2) CN105120856B (zh)
AU (2) AU2014249078B2 (zh)
BR (1) BR112015021931A8 (zh)
CA (1) CA2904046C (zh)
ES (1) ES2708756T3 (zh)
HK (1) HK1217444A1 (zh)
MX (1) MX361647B (zh)
WO (1) WO2014164736A1 (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4025566B2 (ja) * 2002-03-27 2007-12-19 新日本製鐵株式会社 オーステナイト系ステンレス鋼薄帯状鋳片の製造方法
KR20170084354A (ko) 2010-09-24 2017-07-19 유니버시티 오브 플로리다 리서치 파운데이션, 인크. 위장 기능을 증진시키기 위한 물질 및 방법
AU2013216871B2 (en) * 2012-02-08 2017-08-17 University Of Florida Research Foundation, Inc. Materials and methods for treating diarrhea
MX361647B (es) 2013-03-11 2018-12-13 Univ Florida Materiales y métodos para mejorar la función pulmonar y para la prevención y/o tratamiento de complicaciones pulmonares inducidas por radiación.
KR20170058820A (ko) * 2015-11-19 2017-05-29 주식회사 유진테크 머티리얼즈 유기 4족 화합물을 포함하는 전구체 조성물 및 이를 이용한 박막 형성 방법
CA3039514C (en) * 2016-10-04 2022-01-25 University Of Florida Research Foundation, Incorporated Amino acid compositions and uses thereof
WO2018093386A1 (en) 2016-11-21 2018-05-24 Hewlett-Packard Development Company, L.P. Presence identification
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
CN111295187A (zh) 2017-08-14 2020-06-16 胺细拉健康公司 用于治疗肝脏疾病的氨基酸组合物
WO2019070759A1 (en) * 2017-10-02 2019-04-11 University Of Florida Research Foundation Incorporated AMINO ACID COMPOSITIONS AND METHODS FOR TREATING CYSTIC FIBROSIS
EP3810123A1 (en) 2018-06-20 2021-04-28 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
CN109090248A (zh) * 2018-09-11 2018-12-28 内蒙古伊利实业集团股份有限公司 一种用于预防小儿肺炎疾病的营养组合物
EP4084784A4 (en) * 2020-01-13 2024-01-17 Monash University COMPOSITIONS AND METHODS
US11878073B1 (en) 2022-09-20 2024-01-23 Entrinsic, LLC Generation of hydration-targeted formulations and methods of use therein
CN115919847B (zh) * 2023-01-31 2024-05-28 中南大学 吲哚-3-醋酸甲酯在缓解放射诱导肺纤维化方面的应用

Family Cites Families (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1285491C (en) 1985-09-12 1991-07-02 Robert J. Smith Method of treating catabolic dysfunction
SE8601828D0 (sv) 1986-04-21 1986-04-21 Novo Industri As Enteral diet product and agent for production thereof
US5254572A (en) 1987-11-27 1993-10-19 Vesta Medicines (Pty) Ltd. Method and composition for supplementing vitamin B6 where the PN-PLP pathway is disturbed
US5290538A (en) 1988-12-22 1994-03-01 Skrezek Christian Nephro protective infusion solutions
ES2179068T3 (es) 1991-03-05 2003-01-16 Aradigm Corp Metodo y dispositivo para corregir el desplazamiento de deriva de un detector de presion de flujo.
ATE189124T1 (de) 1991-07-02 2000-02-15 Inhale Inc Verfahren und vorrichtung zum abgeben von medikamenten in aerosolform
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US5934272A (en) 1993-01-29 1999-08-10 Aradigm Corporation Device and method of creating aerosolized mist of respiratory drug
US5558085A (en) 1993-01-29 1996-09-24 Aradigm Corporation Intrapulmonary delivery of peptide drugs
NZ248605A (en) 1993-05-28 1994-12-22 Abbott Lab Enteral nutritional product comprising protein and fat
JPH0730853A (ja) 1993-07-14 1995-01-31 Canon Inc 信号処理装置
US6051256A (en) 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
US5780451A (en) 1994-04-01 1998-07-14 Abbott Laboratories Nutritional product for a person having ulcerative colitis
JPH07330583A (ja) 1994-06-03 1995-12-19 Terumo Corp 遊離型グルタミン酸を含有する液状製剤
JPH0873351A (ja) 1994-06-30 1996-03-19 Ajinomoto Co Inc 炎症性腸疾患用栄養組成物
EP0689835A3 (en) 1994-06-30 1996-04-17 Ajinomoto Kk Composition containing an amino acid mixture and at least one N-3 fatty acid
JP4011638B2 (ja) 1994-12-27 2007-11-21 イーエヌ大塚製薬株式会社 経口経腸栄養組成物
AU710527B2 (en) 1995-02-23 1999-09-23 Novartis Nutrition Ag Amino acid compositions and use thereof in clinical nutrition
KR19980703876A (ko) 1995-04-14 1998-12-05 스티븐 엘. 허스트 분산성이 개선된 분말화된 약학적 조성물
US6673355B1 (en) 1995-06-14 2004-01-06 Baylor College Of Medicine Rotavirus enterotoxin NSP4 and methods of using same
CA2224697A1 (en) 1995-06-14 1997-01-03 Peng Tian Rotavirus enterotoxin nsp4 and methods of using same
US5821217A (en) 1995-10-27 1998-10-13 Beth Israel Deaconess Medical Center, Inc. Enteral formulation: low in fat and containing protein hydrolysates
EP0952821A4 (en) 1996-12-31 2006-07-26 Nektar Therapeutics METHODS FOR DRYING AQUEOUS SUSPENSION OF HYDROPHOBIC DRUGS WITH HYDROPHILIC EXCIPIENTS AND COMPOSITIONS PREPARED THEREFROM
JP2002542145A (ja) 1998-11-13 2002-12-10 チルドレンズ・ホスピタル・オヴ・ロス・アンジェルス 血管成長を促進する方法
NZ512383A (en) 1998-12-22 2003-05-30 Univ North Carolina Use of osmotic agents in the treatment of airway diseases and for the delivery of airway drugs
GB0009056D0 (en) 2000-04-12 2000-05-31 Nestle Sa Composition comprising free amino acids
US6956023B1 (en) 2001-04-19 2005-10-18 University Of Florida Materials and methods for providing nutrition to neonates
EP1521735A2 (en) * 2001-05-25 2005-04-13 Ceremedix, Inc Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals
JP4255656B2 (ja) 2001-09-17 2009-04-15 株式会社メニコン 眼科用液剤及びコンタクトレンズ用液剤
US20030105104A1 (en) 2001-11-27 2003-06-05 Burzynski Stanislaw R. Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
US20030143293A1 (en) 2002-01-31 2003-07-31 Sergei Shushunov Compositions and methods for treating diarrhea
JP2004123642A (ja) 2002-10-04 2004-04-22 Shimizu Pharmaceutical Co Ltd 電解質組成物
DK175877B1 (da) 2002-11-11 2005-05-09 Pharmalett As Præparater til anvendelse som terapeutisk middel
US20040213838A1 (en) 2003-04-24 2004-10-28 Mazer Terrence B. Medical food tablets containing free amino acids
US20050100637A1 (en) 2003-11-12 2005-05-12 Robert Murray Carbohydrate and electrolyte replacement composition
FR2864955B1 (fr) 2004-01-08 2006-03-10 Centre Nat Rech Scient Derives du gossypol, leur methode d'obtention et leurs utilisations
WO2005115430A1 (en) * 2004-05-27 2005-12-08 Gropep Limited Treatment of inflammatory airway disease
EP1818053A4 (en) * 2004-11-02 2008-02-27 Ajinomoto Kk MEDICINE FOR THE TREATMENT / PROPHYLAXIS OF ALLERGIC DISEASES
US20070010459A1 (en) 2005-01-14 2007-01-11 Ying Liu Application of asiatic acid and its derivatives to treat pulmonary fibrosis
GB0503337D0 (en) 2005-02-17 2005-03-23 Glaxosmithkline Biolog Sa Compositions
JP4811576B2 (ja) 2005-03-31 2011-11-09 味の素株式会社 水分電解質補給飲料
EP1920770A4 (en) 2005-07-01 2010-09-29 Ajinomoto Kk THERAPEUTIC AGENT AGAINST INFLAMMATORY DISEASE AND TNF ALPHA PRODUCTION DISEASE
US7595079B2 (en) 2005-07-08 2009-09-29 Bomac Vets Plus, Inc. Nutritional conjunctive support therapy for recovery in animals following stress or illness
JP4512013B2 (ja) 2005-09-07 2010-07-28 和光堂株式会社 液体飲料組成物及びその製造方法
US20070202058A1 (en) 2006-02-27 2007-08-30 Calwood Nutritionals, Inc. Compositions for treating gastric reflux
CN100522183C (zh) * 2006-03-02 2009-08-05 上海交通大学 治疗咳喘病的地龙酸性部位药及其制备方法
JP5307559B2 (ja) * 2006-03-07 2013-10-02 バイオテンプト ビー．ブイ． 放射線障害の制御の為にペプチドを使用する方法
EP1864692A1 (en) 2006-06-07 2007-12-12 Biotempt B.V. Use of peptides for the control of radiation injury
DE102006018293A1 (de) 2006-04-20 2007-10-25 Fresenius Kabi Deutschland Gmbh Pädiatrische Aminosäurelösung zur parenteralen Ernäherung
US20070270355A1 (en) 2006-05-11 2007-11-22 Garcia Ramon D Sport drink containing amino acids and carbohydrates
CN101437413A (zh) * 2006-05-12 2009-05-20 可口可乐公司 饮料防腐剂
JP5100033B2 (ja) 2006-05-16 2012-12-19 大塚製薬株式会社 消化管及び腎臓の萎縮抑制剤
GB0612671D0 (en) 2006-06-27 2006-08-09 Shs Int Ltd Nutritional formulation
AU2007280272A1 (en) * 2006-08-04 2008-02-07 Shs International Ltd Protein free formula
PL2114421T3 (pl) * 2007-03-05 2018-07-31 Om Pharma Ekstrakt bakteryjny do stosowania względem zaburzeń oddechowych i sposób jego wytwarzania
BRPI0814745A2 (pt) 2007-08-03 2014-10-07 Aminotech As Composição de produto.
KR101325374B1 (ko) * 2008-02-19 2013-11-08 가부시키가이샤 오츠까 세이야꾸 고죠 신체 기능의 회복에 유용한 경구 또는 경장 조성물
JP5527986B2 (ja) * 2008-02-19 2014-06-25 株式会社アーネストメディスン 医薬組成物
JP5576097B2 (ja) 2009-11-17 2014-08-20 大塚製薬株式会社 気道抵抗改善剤
IT1396935B1 (it) 2009-11-26 2012-12-20 Solartium Entpr Ltd Uso di una combinazione per il trattamento delle mucositi indotte da radiazioni o da chemioterapici
CN101779750A (zh) 2010-03-24 2010-07-21 舒世洪 一种乳猪教槽料及制备方法
WO2011127056A2 (en) 2010-04-05 2011-10-13 The Uab Research Foundation Biomarkers for assessing exposure to ionizing radiation and absorbed dose
WO2012020357A1 (en) 2010-08-09 2012-02-16 Advinus Therapeutics Ltd. Acetamide compounds, their process and pharmaceutical application
KR20170084354A (ko) 2010-09-24 2017-07-19 유니버시티 오브 플로리다 리서치 파운데이션, 인크. 위장 기능을 증진시키기 위한 물질 및 방법
US20120321729A1 (en) * 2011-06-15 2012-12-20 Ven Subbiah Nutritional formula for managing chronic obstructive pulmonary disease (copd) and lung health
US8557301B2 (en) 2011-07-01 2013-10-15 Drip Drop, Inc. Oral rehydration composition
AU2013216871B2 (en) 2012-02-08 2017-08-17 University Of Florida Research Foundation, Inc. Materials and methods for treating diarrhea
ES2691083T3 (es) 2012-04-05 2018-11-23 University Of Florida Research Foundation, Inc. Composición para el tratamiento de fibrosis quística y la inducción de secreción de iones
MX361647B (es) 2013-03-11 2018-12-13 Univ Florida Materiales y métodos para mejorar la función pulmonar y para la prevención y/o tratamiento de complicaciones pulmonares inducidas por radiación.
AU2017204949B2 (en) 2016-01-06 2020-01-16 Parasonic Ltd. Device and method for damaging parasites using ultrasonic reflection
KR101850118B1 (ko) 2016-08-09 2018-04-19 한국생산기술연구원 이동 로봇과 카메라의 캘리브레이션 방법 및 시스템
CA3039514C (en) 2016-10-04 2022-01-25 University Of Florida Research Foundation, Incorporated Amino acid compositions and uses thereof

Also Published As

Publication number Publication date
AU2014249078B2 (en) 2018-07-26
KR20190104250A (ko) 2019-09-06
CA2904046C (en) 2020-01-14
US20230263756A1 (en) 2023-08-24
KR20190040091A (ko) 2019-04-16
KR101969199B1 (ko) 2019-04-15
CN110522744A (zh) 2019-12-03
MX2015011860A (es) 2016-07-07
JP2018184451A (ja) 2018-11-22
US10350185B2 (en) 2019-07-16
JP6378307B2 (ja) 2018-08-22
US11529325B2 (en) 2022-12-20
CN110522744B (zh) 2023-04-07
US20210038551A1 (en) 2021-02-11
AU2018211328B2 (en) 2019-12-19
AU2018211328A1 (en) 2018-08-23
AU2014249078A1 (en) 2015-10-01
KR102060292B1 (ko) 2019-12-27
CN105120856A (zh) 2015-12-02
WO2014164736A1 (en) 2014-10-09
EP3427730B1 (en) 2024-07-10
US20160015664A1 (en) 2016-01-21
EP2968241B1 (en) 2018-10-31
KR20150128779A (ko) 2015-11-18
JP2016512522A (ja) 2016-04-28
MX361647B (es) 2018-12-13
BR112015021931A8 (pt) 2018-01-23
CN105120856B (zh) 2019-07-09
EP2968241A1 (en) 2016-01-20
US20190388378A1 (en) 2019-12-26
BR112015021931A2 (pt) 2017-08-22
US10758507B2 (en) 2020-09-01
ES2708756T3 (es) 2019-04-11
CA2904046A1 (en) 2014-10-09
JP2020196761A (ja) 2020-12-10
JP6806740B2 (ja) 2021-01-06
EP2968241A4 (en) 2016-10-19
EP3427730A1 (en) 2019-01-16

Similar Documents

Publication Publication Date Title
HK1217444A1 (zh) 用於改善肺功能和用於預防和/或治療輻射誘發的肺併發症的材料和方法
HK1225654A1 (zh) 用於治療老花眼的組合物及方法
ZA201604810B (en) Surface treatment of particles and their use
GB201320723D0 (en) Composition and methods of treatment
HK1222395A1 (zh) 用於治療和預防呼吸道合胞病毒感染的氮雜-氧代-吲哚
HK1222398A1 (zh) 治療伯克霍爾德氏菌感染症的組合物及方法
EP2991953A4 (en) COMPOSITION FOR TREATING STONE AND METHOD FOR MANUFACTURING THE SAME
ZA201604860B (en) Surface treatment of particles and their use
EP2968318A4 (en) ANTI-PCSK9 COMPOUNDS AND METHODS FOR TREATING AND / OR PREVENTING CARDIOVASCULAR DISEASES
GB201217296D0 (en) Method of treatment and/or prevention
HUE046924T2 (hu) Módszerek és készítmények Barth szindróma megelõzésében vagy kezelésében történõ alkalmazásra
HRP20190219T1 (hr) Spojevi za tretman pretilosti i postupci za njihovu uporabu
HK1220374A1 (zh) 用於治療碳氧血紅蛋白血症的組合物和方法
HK1220213A1 (zh) 腎病綜合征及相關病狀的治療方法
HK1222389A1 (zh) 肺病症和其他病症的治療
HK1206594A1 (zh) 預防和治療病毒感染的材料和方法
EP3079657B8 (en) Preparation for prevention and/or treatment of peri-implantitis
EP2981324A4 (en) METHODS AND ARTICLES MANUFACTURED FOR THE TREATMENT OF SKIN
EP2941248A4 (en) COMPOSITION AND METHOD FOR TREATING BODY SURFACE
GB201309001D0 (en) Methods for prevention and treatment of preeclampsia
ZA201408732B (en) Composition and methods for treating wounds
SI3010496T1 (sl) Arginin za uporabo pri zdravljenju in/ali preprečevanju osteoartritisa
GB201317373D0 (en) Treatment and prevention of cancer